Last reviewed · How we verify

NCT06269224

Examining Factors Influencing Thoracolumbar Mobility in Runners

Completed Last updated 22 February 2024
What this trial tests

trial testing Participants were recreational runners who run between 20 to 50 km weekly; each one has 35 runners. in Runners in 90 participants. Completed in 1 January 2024.

Timeline
1 September 2022
Primary endpoint
1 January 2023
1 January 2024

Quick facts

Lead sponsorHacettepe University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment90
Start date1 September 2022
Primary completion1 January 2023
Estimated completion1 January 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Hacettepe University

Who can join

Adults 30 to 45, any sex, with Runners or Mobility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The presence of to is thoracolumbar (TL) mobility a significant aspect in the context of running. Most of the factors may be related to certain kinematic parameters of the lumbopelvic-hip complex during running.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Hacettepe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06269224.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing